2021 Poster Presentations

 

P01: Accelerating SARS-CoV-2 Therapeutic Development: Matrix and Drug-Tolerant Automated PK and ADA Actemra (tocilizumab) Microfluidic Immunoassays, Presented by James S., Gyros Protein Technologies

P02: Challenges in Production of High Purity Marburg Recombinant Glycoprotein for ELISA, Presented by Jocelyn J., Sabin Vaccine Institute

P03: Development and Characterization of a Reporter Gene Cell Line for the Easy Assessment of Therapeutic AAV Vectors - An iLite® Case Study, Presented by Erfan E., Svar Life Science AB

P04: False Positive Rates at 1-5% Are Too High for Drugs with Low Immunogenicity, Presented by James X., AstraZeneca

P05: In Vitro Assessment of the Innate Immune Responses to Teriparatide, Presented by Claire H., Frederick National Laboratory for Cancer Research

P06: Minor Changes in Fucosylation have a Large Impact on Potency Measurements in an ADCC Reporter Gene Assay, Presented by Robert A., Merck & Co., Inc.

 


Register